Human S100A9 (S100Calcium Binding Protein A9) ELISA Kit

Specifications

Catalog number

E-EL-H6197-01

Size / count

24 Tests

Dry ice

No

Hazardous

No

Discontinued

No

Abbreviation

S100A9

UniProt

P06702

Cross Reactivity

This kit recognizes Human S100A9 in samples. No significant cross-reactivity or interference between Human S100A9 and analogues was observed.

Target

MRP14;60B8AG; CAGB; CFAG; CGLB; L1AG; LIAG; MAC387; MIF; NIF; P14; Calgranulin-B

Type

Sandwich-ELISA

Applications

ELISA

Field of Research

Cancer; Immunology; Signal transduction

Assay Principle

This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human S100A9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human S100A9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human S100A9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human S100A9. You can calculate the concentration of Human S100A9 in the samples by comparing the OD of the samples to the standard curve.

Assay Performance Time

3 h 30 min

Sample Type

Serum, plasma and other biological fluids

Detection Range

0.31-20 pg/mL

Precision

Both intra-CV and inter-CV are < 10%.

Recovery

80%-120%

Sensitivity

0.12 pg/mL

Shipping Conditions

Ice bag

Storage Conditions

2-8°C,12 months

Detection Instrument

Microplate reader

Species

Human

Recommended Usage

This ELISA kit applies to the in vitro quantitative determination of Human S100A9 concentrations in serum, plasma and other biological fluids.